We are live on
!
Find out more
BC
Blackcrane Capital Portfolio holdings
AUM
$16.3M
1-Year Est. Return
19.53%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
-19.53%
3 Year Est. Return
+40.04%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$63.5M
AUM Growth
+$12.5M
(+25%)
Cap. Flow
+$12.5M
Cap. Flow
% of AUM
19.66%
Top 10 Holdings %
Top 10 Hldgs %
94.26%
Holding
15
New
4
Increased
6
Reduced
3
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aurinia Pharmaceuticals
AUPH
|
+$7.3M |
| 2 |
Avita Medical
RCEL
|
+$2.55M |
| 3 |
PROF
Profound Medical
PROF
|
+$2.49M |
| 4 |
Alibaba
BABA
|
+$2.47M |
| 5 |
MYOV
Myovant Sciences Ltd.
MYOV
|
+$1.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$3.14M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$2.2M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$1.1M |
| 4 |
Open Text
OTEX
|
+$393K |
| 5 |
Takeda Pharmaceutical
TAK
|
+$372K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.51% |
| 2 | Technology | 41.34% |
| 3 | Consumer Discretionary | 3.59% |
| 4 | Financials | 2.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
WIX.com
WIX
$2.15B
| $12.3M | 19.35% |
43,963
+1,600
| +4% | +$457K |
|
|
PROF
2
Profound Medical
PROF
$249M
| $8.96M | 14.12% |
445,525
+103,758
| +30% | +$2.49M |
|
|
3
Avita Medical
RCEL
$157M
| $8.29M | 13.06% |
418,194
+109,690
| +36% | +$2.55M |
|
|
4
Open Text
OTEX
$5.65B
| $6.84M | 10.78% |
143,400
-8,400
| -6% | -$393K |
|
|
5
Aurinia Pharmaceuticals
AUPH
$2.05B
| $6.54M | 10.3% |
+503,248
| New | +$7.3M |
|
6
Nice
NICE
$5.87B
| $5.98M | 9.42% |
27,418
+697
| +3% | +$174K |
|
|
AXNX
7
DELISTED
Axonics, Inc. Common Stock
AXNX
| $4.01M | 6.32% |
66,996
-57,740
| -46% | -$3.14M |
|
|
MYOV
8
DELISTED
Myovant Sciences Ltd.
MYOV
| $2.92M | 4.61% |
142,065
+72,370
| +104% | +$1.65M |
|
|
9
Alibaba
BABA
$276B
| $2.28M | 3.59% |
+10,041
| New | +$2.47M |
|
|
10
Takeda Pharmaceutical
TAK
$54.8B
| $1.72M | 2.72% |
14,571
-20,665
| -59% | -$372K |
|
11
HDFC Bank
HDB
$135B
| $1.63M | 2.57% |
+41,956
| New | +$1.64M |
|
12
Microsoft
MSFT
$2.93T
| $1.14M | 1.79% |
4,826
+271
| +6% | +$62.9K |
|
13
ClearPoint Neuro
CLPT
$454M
| $872K | 1.37% |
+41,266
| New | +$883K |
|
|
14
Neurocrine Biosciences
NBIX
$17.2B
| – | – |
-11,499
| Closed | -$1.1M |
|
|
BHVN
15
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-25,641
| Closed | -$2.2M |
|
Similar funds
FQ
AG
SCM
CFG
YEPV
WIA
LSM
FFIM
Blackcrane Capital's Q1 2021 Portfolio in Review
As of Q1 2021, Blackcrane Capital held 15 positions worth $63.5M, up 25% from $50.9M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
Blackcrane Capital deployed $12.5M of net new capital in Q1 2021, opening 4 new positions and adding to 6 existing holdings. Its largest new stake was Aurinia Pharmaceuticals: 503,248 shares worth $6.54M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 49% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Axonics, Inc. Common Stock, an estimated $3.14M trimmed.
- Blackcrane Capital's largest Q1 2021 buy was Aurinia Pharmaceuticals: 503,248 shares worth $6.54M.
- Blackcrane Capital added most to Avita Medical in Q1 2021, an estimated $2.55M increase.
- Blackcrane Capital's biggest Q1 2021 reduction was Axonics, Inc. Common Stock, cutting an estimated $3.14M.
- Blackcrane Capital fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q1 2021, selling an estimated $2.2M.
- Blackcrane Capital's ten largest holdings make up 94% of its $63.5M portfolio in Q1 2021.
- Blackcrane Capital opened 4 new positions and closed 2 in Q1 2021.
- Blackcrane Capital's portfolio value rose 25% quarter-over-quarter to $63.5M.
Based on Blackcrane Capital's 13F filing for Q1 2021, filed 13 May 2021.